Treatment challenges for community oncologists treating postmenopausal women with endocrine-resistant, hormone receptor-positive, human epidermal growth factor receptor 2-negative...

Por Gradishar, William J
Publicado no Cancer Manag Res (2016)

Advances in breast cancer management

Por Gradishar, William J., Wood, William C.
Publicado em 2008

nab-Paclitaxel for first-line treatment of patients with metastatic breast cancer and poor prognostic factors: a retrospective analysis

Por O’Shaughnessy, Joyce, Gradishar, William J., Bhar, Paul, Iglesias, Jose
Publicado em 2013

Barriers to the Use of Personalized Medicine in Breast Cancer

Por Weldon, Christine B., Trosman, Julia R., Gradishar, William J., Benson, Al B., Schink, Julian C.
Publicado em 2012

ERK-regulated αB-Crystallin Induction by Matrix Detachment Inhibits Anoikis and Promotes Lung Metastasis in vivo

Por Malin, Dmitry, Strekalova, Elena, Petrovic, Vladimir, Rajanala, Harisha, Sharma, Bhawna, Ugolkov, Andrey, Gradishar, William J., Cryns, Vincent L.
Publicado no Oncogene (2015)

A phase II trial of capecitabine in combination with the farnesyltransferase inhibitor tipifarnib in patients with anthracycline-treated and taxane-resistant metastatic breast canc...

Por Li, Tianhong, Guo, Mengye, Gradishar, William J., Sparano, Joseph A., Perez, Edith A., Wang, Molin, Sledge, George W.
Publicado no Breast Cancer Res Treat (2012)

A phase II trial of trastuzumab plus weekly ixabepilone and carboplatin in patients with HER2-positive metastatic breast cancer: an Eastern Cooperative Oncology Group Trial

Por Moulder, Stacy, Li, Hailun, Wang, Molin, Gradishar, William J., Perez, Edith A., Sparano, Joseph A., Pins, Michael, Yang, Ximing, Sledge, George W.
Publicado em 2010

A phase 3 tRial comparing capecitabinE in combination with SorafenIb or pLacebo for treatment of locally advanced or metastatIc HER2-Negative breast CancEr (the RESILIENCE study):...

Por Baselga, José, Costa, Frederico, Gomez, Henry, Hudis, Clifford A, Rapoport, Bernardo, Roche, Henri, Schwartzberg, Lee S, Petrenciuc, Oana, Shan, Minghua, Gradishar, William J
Publicado em 2013

Developmental therapeutics for inflammatory breast cancer: Biology and translational directions

Por Costa, Ricardo, Santa-Maria, Cesar A, Rossi, Giovanna, Carneiro, Benedito A, Chae, Young Kwang, Gradishar, William J, Giles, Francis J, Cristofanilli, Massimo
Publicado no Oncotarget (2016)

Oncology Fellows' Career Plans, Expectations, and Well-Being: Do Fellows Know What They Are Getting Into?

Por Shanafelt, Tait D., Raymond, Marilyn, Horn, Leora, Moynihan, Tim, Collichio, Frances, Chew, Helen, Kosty, Michael P., Satele, Daniel, Sloan, Jeff, Gradishar, William J.
Publicado no J Clin Oncol (2014)

Yttrium-90 radioembolization stops progression of targeted breast cancer liver metastases after failed chemotherapy: (90)Y Radioembolization for BCLM

Por Gordon, Andrew C., Gradishar, William J., Kaklamani, Virginia G., Thuluvath, Avesh J., Ryu, Robert K., Sato, Kent T., Gates, Vanessa L., Salem, Riad, Lewandowski, Robert J.
Publicado no J Vasc Interv Radiol (2014)

Burnout and Career Satisfaction Among US Oncologists

Por Shanafelt, Tait D., Gradishar, William J., Kosty, Michael, Satele, Daniel, Chew, Helen, Horn, Leora, Clark, Ben, Hanley, Amy E., Chu, Quyen, Pippen, John, Sloan, Jeff, Raymond, Marilyn
Publicado em 2014

Satisfaction With Work-Life Balance and the Career and Retirement Plans of US Oncologists

Por Shanafelt, Tait D., Raymond, Marilyn, Kosty, Michael, Satele, Daniel, Horn, Leora, Pippen, John, Chu, Quyen, Chew, Helen, Clark, William Benton, Hanley, Amy E., Sloan, Jeff, Gradishar, William J.
Publicado no J Clin Oncol (2014)

Biomarker Testing for Breast, Lung, and Gastroesophageal Cancers at NCI Designated Cancer Centers

Por Schink, Julian C., Trosman, Julia R., Weldon, Christine B., Siziopikou, Kalliopi P., Tsongalis, Gregory J., Rademaker, Alfred W., Patel, Jyoti D., Benson, Al B., Perez, Edith A., Gradishar, William J.
Publicado em 2014

Metastatic Breast Cancer, Version 1.2012: Featured Updates to the NCCN Guidelines

Por Carlson, Robert W., Allred, D. Craig, Anderson, Benjamin O., Burstein, Harold J., Edge, Stephen B., Farrar, William B., Forero, Andres, Giordano, Sharon Hermes, Goldstein, Lori J., Gradishar, William J., Hayes, Daniel F., Hudis, Clifford A., Isakoff, Steven Jay, Ljung, Britt-Marie E., Mankoff, David A., Marcom, P. Kelly, Mayer, Ingrid A., McCormick, Beryl, Pierce, Lori J., Reed, Elizabeth C., Smith, Mary Lou, Soliman, Hatem, Somlo, George, Theriault, Richard L., Ward, John H., Wolff, Antonio C., Zellars, Richard, Kumar, Rashmi, Shead, Dorothy A.
Publicado em 2012

Breast Cancer, Version 3.2013: Featured Updates to the NCCN Guidelines

Por Theriault, Richard L., Carlson, Robert W., Allred, Craig, Anderson, Benjamin O., Burstein, Harold J., Edge, Stephen B., Farrar, William B., Forero, Andres, Giordano, Sharon Hermes, Goldstein, Lori J., Gradishar, William J., Hayes, Daniel F., Hudis, Clifford A., Isakoff, Steven J., Ljung, Britt-Marie E., Mankoff, David A., Marcom, P. Kelly, Mayer, Ingrid A., McCormick, Beryl, Pierce, Lori J., Reed, Elizabeth C., Schwartzberg, Lee S., Smith, Mary Lou, Soliman, Hatem, Somlo, George, Ward, John H., Wolff, Antonio C., Zellars, Richard, Shead, Dorothy A., Kumar, Rashmi
Publicado em 2013